To further certify the existence of the trade-off pressure to decrease copy number in this genomic region, the copy number profiles of the AKT family (AKT1, AKT2, and AKT3) and MARK family (MARK1, MARK2, MARK3, and MARK4) were interrogated across a variety of cancer types. This evidence concerns the gene MARK2 and cancer.